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1. Introduction
In the 21st century, corporations are the dominant global organizational form.
Of the 100 largest economies in the world in 2000, 51 were corporations and the
combined sales of the world’s top 200 corporations were larger than the combined
economies of all countries excluding the biggest 10 (Anderson & Cavanagh, 2000).
Today corporations influence every aspect of human experience, from diet, air
pollution, work, and health care to personal identity, life style, sexuality, and gover-
nance. As corporations have displaced prior social influences, such as religion,
family, community, and government, their impact on health has also increased.
Although the preponderance of evidence suggests that the overall burden of disease
imposed by consumer products such as tobacco, high fat-low nutrient foods, auto-
mobiles, and firearms is large and growing (Choi, Hunter, Tsou, & Sainsbury, 2005;
Richmond, Cheney, & Schwab, 2005; Yach, Hawkes, Gould, & Hofman, 2004)
public health researchers have rarely studied corporations or the free markets in
which they are embedded as direct social determinants of health. Instead, they have
focused on the social stratification, stresses, and inequities that the market system
creates, leaving relatively unexamined the pathways by which corporate decisions
influence population health.
In this chapter, we summarize the various ways that corporations influence
health, then describe in more detail one increasingly important pathway – the
impact on health of the products corporations manufacture and sell and their
practices to maximize such sales. Finally, we examine the public health response
to health-damaging corporate behaviors and suggest research and practice strate-
gies to reduce their harm.
2. Corporations as a Social Determinant of Health
The corporation first emerged in Europe in the 16th and 17th centuries as a
way of pooling capital in order to invest in commercial opportunities that no
single investor could realize on his own. In the 19th century, corporations
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helped to amass the capital necessary for building the railways, canals, and
other infrastructure needed to sustain the Industrial Revolution. By the end of
that century, both England and United States had passed laws that limited the
personal liability of investors for the harm caused by their business activity
and that loosened controls on mergers and acquisitions (Bakan, 2004; Berle &
Means, 1968; Galbraith, 1952). These changes set the framework for the
modern corporation, which Ambrose Bierce jocularly defined in 1911 as “an
ingenious device for obtaining individual profit without individual responsi-
bility” (Bierce, 1911).
In the past century, corporations have penetrated almost every sector of human
experience. They set patterns of employment and working conditions for a signif-
icant sector of the working population (Hippert, 2002; LaDou, 2003), are a dom-
inant voice in welfare, tax, trade, health care, and environmental policies within
many nations and global organizations (Fort, Mercer, & Gish, 2004; Pollock &
Price, 2003; Waitzkin, Jasso-Aguilar, Landwehr, & Mountain, 2005), and shape
patterns of consumption and life style through the products they make and their
advertising (Cross, 2002; De Graaf, Wann, & Naylor, 2001; Hawkes, 2006;
Schor, 2004). They also increasingly operate privatized services, such as health
care, education, corrections, and security, that were previously public (Sclar &
Leone, 2001); control growing sectors of public space and media (Bagdikian,
2004; Mitchell, 2003); and influence individual consciousness in such diverse
areas as family life, sexuality, body image, and self-worth (Schor & Holt, 2000).
Through these and other pathways, corporations have become a major influence
on individual and population health.
2.1. Levels of Analysis
The multiple pathways by which corporations influence health require
researchers to focus their investigations on a specific level of analysis. In
previous health research, these have included the free market capitalist sys-
tem as a whole, a specific national economy, a particular industry, a single
company, or a single product. Table 4.1 lists examples of research questions
and selected studies at these different levels. Each approach has distinct
advantages and disadvantages, depending on the objectives of the analyst. For
example, advocates seeking to reduce gun violence might choose to look at
the firearms industry as a whole to identify opportunities for policy interven-
tion, while those seeking to remove trans fat from food products to prevent
cardiovascular disease and diabetes may focus on this single but pervasive
product.
Since a comprehensive review of the findings of each level of analysis is
beyond the scope of this chapter, we seek to more generally explore the health
impact of the business and political activities of corporations. These practices
result from companies’ decisions about production, pricing, distribution, and pro-
motion of their products and from their political efforts to create an environment
favorable for their business. Our focus is less “fundamental” than the capitalist
system as a whole but less proximate than the individual behaviors that corporate
practices encourage.
Compared to analyses that study the health impact of the capitalist system (or
any other system) as a whole, the focus employed here has greater potential for
informing policies that can improve population health in the medium term.
Given the current absence of social forces that can promise substantive transfor-
mation of the dominant global socioeconomic system, our more modest perspec-
tive appears to have more pragmatic public health value. Nevertheless, some
believe that the system of social stratification, unequal distribution of resources,
and market displacement of the public sector is itself the cause of current
patterns of mortality and morbidity. For them, our perspective suggests more
limited changes that may seem more symbolic than substantive. For example,
ending advertising of harmful products to children and promoting strict regula-
tion of products whose social costs may exceed their benefits, such as trans fats
or Sport Utility Vehicles (SUVs), may seem too modest for those seeking more
fundamental changes.
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TABLE 4.1. Levels of analysis of health consequences of corporate system.
Level Research questions Selected references
Free market system What are the overall health consequences Navarro, 2004; 
as a whole of free market capitalism? How does Engels, 1987;
global economic system explain global 
disparities in health?
National/regional What is the relationship of a Stillman, 2006; Navarro & 
economy nation’s or region’s (e.g. European Union, Schmitt, 2005
NAFTA nations) economic and political 
system on health and health disparities? 
How do differences in market systems 
between two nations/regions explain 
differences in health?
Specific industry What are the health benefits and costs of Stebbins, 1990
an industry (e.g. tobacco) on a nation, 
region or the globe?
Specific company What are the health consequences Spencer, Frank, &  
of a specific company (e.g. McDonald’s) McIntosh, 2005
on global, national or local health?
Specific product What are the health consequences of a Cummings, 2002
particular product (e.g., SUVs) on global, 
national or local health?
Industry practices What is the impact of specific practices Austin, Melly, Sanchez, 
(e.g., advertising, retail practices) Patel, Buka, & 
on global, national or local population Gortmaker, 2005
health? What is the attributable risk of a 
specific practice to selected outcomes or 
compared to other practices (e.g. impact of 
tobacco advertising or comparison of 
advertising and pricing)?
2.2. Corporate Practices that Influence Health
Corporations have an impact on health through their production processes,
through their engagement in the political process, and through public con-
sumption of the goods and services they produce. Production processes can
influence health by exposing workers to unhealthy or unsafe working condi-
tions. The International Labour Organization (ILO) estimates that among the
world’s 2.7 billion workers, at least 2 million deaths per year and many more
illnesses and injuries are attributable to occupational diseases and injuries. The
ILO also estimates that on average about 4 percent of the gross domestic prod-
uct (GDP) of a nation is lost because of work-related diseases and injuries
(Rosenstock, Cullen, & Fingerhut, 2006). In the United States, the economic
costs of job-related injuries ($145 billion) and illnesses ($26 billion) are much
higher than those for AIDS and Alzheimer’s disease and are on par with those
for cancer and circulatory diseases (Leigh, Markowitz, Fahs, Shin, &
Landrigan, 1997). Studies of the proportion of deaths attributable to the prac-
tices of corporations are generally lacking; however, the recent history of
occupational health shows strong corporate opposition to health and safety
measures that reduce profit, challenge managerial authority, or increase
government involvement in corporate oversight (Gochfeld, 2005; Rosner &
Markowitz, 1989).
Production processes can also have a larger impact on health by exposing the
population as a whole to the various pollutants or environmental damage that are
manufacturing by-products Corporate influence on environmental health has
increased dramatically in the 20th century. Corporate actions have contributed to
global warming, deforestation, ozone depletion, and air pollution (McNeill,
2000), each associated with specific causes of mortality and morbidity (Guerra,
Snow, & Hay, 2006; Haines & Patz, 2004; McMichael, 2001). Business deci-
sions regarding which manufacturing products to use and which control tech-
nologies to install determine the environmental consequences of their production
processes.
Corporations also influence health through their engagement in the political
process. Their activities in this arena have a direct effect on health through their
efforts to create favorable occupational, environmental, consumer regulatory,
and other policies. Corporations shape health indirectly through lobbying on
trade, taxation, defense, human services, education, and other issues. For exam-
ple, free trade policies espoused by multinational food companies have
increased the availability and lowered the cost of high fat, high sugar foods,
contributing to obesity and diabetes (Hawkes, 2006). Corporations seek to
lower taxes both by locating operations off shore and by changing tax law,
thus reducing government revenues available for health and human services.
In health care, global health companies advocate for privatization of health
services, making these services less available to the poor and less accessible to
public oversight (Waitzkin et al., 2005).
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Figure 4.1 provides a conceptual model for the hypothesized pathways by
which corporations influence health; the focus of this chapter is on the shaded
portions of the figure that describe the impact of corporate practices on
consumers. For the sake of brevity, we consider corporations and their allies,
e.g., trade groups, lobbyists, lawyers, public relations firms, and retailers, as a
single system. In fact, empirical research demonstrates complex relationships
among these corporate partners (e.g., Hemenway, 2004; Kluger, 1997; Nestle,
2002), suggesting the need for further work to clarify the implications for public
health intervention.
We further focus on six industries – alcohol, automobiles, firearms, food and
beverages, pharmaceuticals, and tobacco. We selected these six because their
products play a central role in mortality and morbidity in the developed world,
their size makes them key players in the economy of the US as well as other
developed and developing nations, and each has elicited public health efforts to
modify harmful practices (illustrated by the box labeled “advocacy groups” in
Figure 4.1). In addition, an extensive literature describes the health consequences
of their products and, to a lesser extent, the role of corporate practices in shaping
health risks, thus permitting a more systematic review of the findings of this body
of literature. Table 4.2 summarizes the health impact of the products of these
industries.
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FIGURE 4.1. A conceptual model of the influence of corporate practices on health.
3. Summary of Evidence on Impact 
of Corporate Practices on Health
Four broad corporate practices have been linked to health outcomes: production
and design, marketing, retail distribution, and pricing. Figure 4.2 lists the various
mechanisms through which decisions in each practice can influence health. In
this section, we review selected evidence to illustrate the pathways and mecha-
nisms by which corporate practices in the target industries (alcohol, automobiles,
firearms, food and beverages, pharmaceuticals, and tobacco) influence health and
to illuminate future research needs and opportunities for intervention. In order to
consider a wide range of relevant research, we include not only studies that have
explicitly linked corporate practices to particular health indicators, but also those
that examine the associations between corporate practices and health behaviors,
e.g., tobacco use, diets associated with obesity, etc. We note that the availability
and previous synthesis of evidence varies widely by industry. Tobacco, for exam-
ple, has been studied most systematically; the literature on the food industry and
health is only now expanding rapidly, while the literature on the firearms and
pharmaceutical industries is sparser. Our goal is to highlight evidence that illus-
trates how practitioners and researchers have gone about examining the link
between corporate practices and health. In the future, systematic reviews of the
health impact of corporate practices by industry, practice, and health outcome are
needed to advance our understanding.
3.1. Production and Design
Production and design refers to business decisions about where to invest capital
and about the specific characteristics of a product. In market economies, corpo-
rate managers are expected to maximize profit for shareholders; failure to do so
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TABLE 4.2. Health impact of selected consumer products.
Industry/products Health impact Selected references
Alcohol Motor vehicle accidents, cirrhosis, liver Centers for Disease Control 
cancer, homicide, and suicide (CDC), 2004
Automobiles and other Air pollution related respiratory diseases White, 2004; Environmental 
motor vehicles and cancer; driver, passenger, and Protection Agency, 2004
pedestrian injuries and deaths
Food and beverages Obesity, heart disease, diabetes, Katz, O’Connell, Yeh, 
some cancers Nawaz, Njike, Anderson, 
Cory, & Dietz, 2005
Firearms Homicide, suicide, accidental Centers for Disease Control 
and intentional injuries (CDC), 1999
Pharmaceuticals Overuse, toxic effects Centers for Disease Control 
(CDC), 2005
Tobacco Cancers, heart disease, respiratory Stratton, Shetty, Wallace, &
diseases Bondurant, 2001
constitutes fiduciary neglect of their main responsibility (Friedman, 1982). A first
step in maximizing profit is to assure that capital is invested in the most profitable
ventures available, which are constrained by corporate history, technology,
competitors, and law. A second step is to design a particular product so as to
maximize profits. Unfortunately, as the following examples illustrate, the deci-
sions about where to invest capital and how to design products may run counter
to health.
3.1.1. Shifting Capital to Production of more Profitable 
but Less Healthy Products
To maximize profits, a company or industry can decide to shift its capital from the
production of a less damaging to a more health damaging product in order to
maximize profit. Sport Utility Vehicles (SUVs) provide a recent example. From
the early 1990s to 2005, SUVs have been the best-selling and most profitable
vehicles made by the US auto industry; each vehicle returns a profit 10–12 times
higher than for conventional cars. During the 1990s, US auto makers invested bil-
lions of dollars in new factories to build these vehicles, meanwhile reducing their
focus on producing less polluting and more fuel-efficient vehicles.
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FIGURE 4.2. Overview of Corporate Practices that Harm Health
SUVs are characterized by a pick-up truck underbody, high ground clearance,
enclosed rear cargo area, and available 4-wheel drive (Bradsher, 2002). SUVs,
together with pickup trucks and minivans, are considered “light trucks,” a category
that has its own regulatory standards separate from that of passenger cars. By
2000, light trucks accounted for 40 percent of US motor vehicles, double the 1980
rate (Coate & Vanderhoff, 2001).
SUVs pose several health and environmental problems. Because of their
design, compared with other vehicles they are more likely to roll over, more likely
than sedans to kill pedestrians and occupants of cars they hit, harder to steer, take
longer to stop, and more likely to give their drivers a false sense of security that
leads to riskier driving. They also produce more pollution than passenger cars,
contributing to respiratory disease, cancer, global warming, and other conditions
(Bradsher, 2002; Environmental Protection Agency, 2004; Haines & Patz, 2004;
National Highway Traffic Safety Administration, 2005; White, 2004). Based on a
review of scientific and government reports, Bradsher (2002) estimates that
through the previously described mechanisms, SUVs account for roughly 3,000
excess deaths per year.
In recent years, rising gas prices and increased public concerns about
SUV safety and pollution led to sharp declines in sales. US auto manufacturers
find it difficult to abandon this sector of the market, however, because of their
heavy investment in SUV production, the high unit profitability of SUVs, and
the stiff competition from foreign auto makers in other sectors of the business
(Wald, 2006).
In the last several decades, the food and beverage industries has chosen to
use corn-based fructose rather than other sweeteners in processed foods and
sweetened drinks. Between 1970 and 1990, the consumption of high fructose
corn syrup increased by more than 1000%, far exceeding the changes in intake
of any other food or food group (Bray, Nielsen, & Popkin, 2004). A variety of
evidence suggests that these products have contributed to the epidemics of
obesity and diabetes (Bray et al., 2004), yet government subsidies and changes
in food production make corn syrup cheap and therefore highly profitable
(Pollan, 2006).
Similarly, the decision by several domestic gun manufacturers to invest in and
significantly increase production of “Saturday night special” handguns in the
1980s and 1990s contributed to an increase in homicides in that period
(Hemenway, 2004: 133). According to one study, 60 percent of guns traced to
crimes in the early 1990s were produced by Southern California’s “Ring of Fire”
gun makers, who had recently expanded production of Saturday night specials
(Wintemute, 1994).
In another example, pharmaceutical companies make investment decisions that
adversely affect population health when they do not develop products that are life
saving but unprofitable (e.g., vaccines (Andre, 2002)), often known as “orphan
drugs” (Schieppati, Remuzzi, & Garattini, 2001), or to create products that are
unnecessary but profitable, a practice labeled as “disease mongering” (Moynihan &
Cassels, 2005).
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3.1.2. Designing Features that Harm Health but Increase Profit
A second mechanism by which corporate practices can influence health is when
producers modify their products in ways that harm health, often in order to
increase sales or profits or reduce costs. The addition of trans fats to hundreds of
US food products in the last four decades illustrates how product design intended
to increase shelf life, and therefore profitability, can have dire health conse-
quences. Trans fats are solid fats produced artificially by heating liquid vegetable
oils in the presence of metal catalysts and hydrogen (Ascherio, Stampfer, &
Willett, 1999). They are used to enhance the crispness, creaminess, stability, fla-
vor, and shelf life of many processed and fast foods. By the late 1990s, roughly 40
percent of supermarket products contained trans fats, commonly identified on
labels as partially-hydrogenated fats. In 1994, the Center for Science in the Public
Interest (CSPI), a national advocacy organization, petitioned the Food and Drug
Administration (FDA) to require that food manufacturers label the trans fatty acid
(trans fat) content of their food products. The petition was based on new research
showing that replacing trans fat with healthier oils could prevent between 30,000
and 100,000 premature cardiovascular deaths in the United States each year
(Willett et al., 1993). In 1999, the FDA estimated that strengthening food labeling
was likely to yield significant health and economic benefits, including saving
2,100 to 5,600 lives a year and $3 billion to $8 billion a year (Food and Drug
Administration, 1999). Not until 2006, however, did new regulations go into effect
requiring food companies to list the trans fat content on nutritional labels.
3.1.3. Resisting Addition of Health Enhancing Features
in Order to Avoid Increasing Production Costs
In some cases, failure to change product design harms health. The auto industry
has initially resisted almost every proposed safety or pollution reduction feature:
e.g., mandatory seat belts, air bags, and improved fuel efficiency (Doyle, 2000).
As early as 1965, Ralph Nader, in his book Unsafe at Any Speed: The Designed-
In Dangers of the American Automobile (1965), described many examples of auto
industry reluctance to spend money on improving safety.
The food industry also resists making changes. If the next 100 billion McDonald’s
burgers sold were vegetable-based rather than beef-based burgers, they would pro-
vide an additional 1 billion pounds of fiber and 660 million pounds of protein and
would reduce saturated fats and total fat by 550 million pounds and 1.2 billion
pounds, respectively (Spencer, Frank, & McIntosh, 2005). The higher profitability of
meat-based products in the present economy makes such a transformation unlikely.
In another example, redesigning handguns and other firearms to include trigger
locks, magazine safety devices, and owner identification systems and avoiding
making guns that can be mistaken for toys could substantially reduce accidental
and intentional injuries and deaths (Carbone, Clemens, & Ball, 2005; Hemenway,
2004). Despite evidence that gun locks and other safety features can mitigate the
adverse consequences of guns in the home (Carbone et al., 2005), gun makers
have resisted government efforts to make such features required or more routinely
available (Siebel, 2000).
4. Corporate Practices 79
3.1.4. Shifting Investment or Redesigning Products to Reach New Markets
where Harm to Health may be Greater
In another pathway, companies or industries make production or design decisions
that result in new populations being exposed to harmful products. For example,
liberalization of trade policies beginning in the 1980s and culminating in the 1994
North American Free Trade Agreement opened new opportunities for transna-
tional food companies to invest and profit in Mexico. Between 1987 and 1999, for
example, direct US investment in Mexican food processing companies increased
from US$210 million to US$5.3 billion, a 25-fold increase. As a result, these
companies sold more processed food in Mexico, per capita consumption of snack
foods and carbonated beverages increased substantially, and obesity rates
increased by more than 75 percent (Hawkes, 2006).
Similarly, when the regulatory environment and public opinion became less
favorable to tobacco in the United States, the tobacco industry decided to invest in
developing nations with less burdensome regulations (Mackay, 1992; Stebbins,
1990). In these nations, not only does tobacco directly impose future health prob-
lems on millions of people, expenditures on tobacco and its health consequences
divert precious limited resources away from desperately needed basic human
requirements (Stebbins, 1990).
Designing products to appeal to a new demographic group can expose additional
people to a harmful product. If the targeted population happens to have a greater
vulnerability (e.g., because of age, socioeconomic status, gender or other character-
istics), these corporate decisions may contribute to the exacerbation of health dis-
parities. For example, RJ Reynolds redesigned Camel cigarettes by including an
additive to reduce throat irritation (Wayne & Connolly, 2002), and some companies
have introduced cigarette brands with candy-like flavors (Carpenter, Wayne, Pauly,
Koh, & Connolly, 2005); both of these changes were designed to appeal to young
smokers. The tobacco industry also added menthol to attract women (O’Keefe &
Pollay, 1996) and African-Americans (Sutton & Robinson, 2004), contributing to
increased smoking rates among these groups (Ezzati & Lopez, 2003).
Similarly, in the last decade, the alcohol industry has developed and marketed
wine coolers and “alcopops,” sweetened alcoholic drinks designed to appeal to
young drinkers (Mosher & Johnsson, 2005). Alcopops are frozen sweetened prod-
ucts that contain fruit juices and alcohol, a product that has been called “training
wheels for drinkers” by public health advocates and that an industry spokesperson
called “the perfect bridging beverage.” The tobacco and alcohol industries invest
capital in designing products that attract and retain future customers, counting on the
addictive properties of their products to hold on to at least some portion of initiators.
3.1.5. Failing to Test for Safety Prior to Production or Marketing
To save money or the time needed to get a product to market, companies some-
times fail to test a product for safety adequately or ignore early warnings about
possible harm. It now seems apparent that Merck failed to test Vioxx sufficiently
prior to production and marketing and ignored potentially troublesome findings
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in its own research (Topol, 2004). Both the Bridgestone/Firestone North
American Tire Company and Ford Motor Company blamed each other for failing
to act earlier on information that Ford Explorer SUVs equipped with Firestone
tires had higher rates of accidents than comparable vehicles with other tires
(Vernick, Mair, Teret, & Sapsin, 2003).
3.2. Marketing
Marketing describes corporate strategies and activities to encourage consumption
and increase demand. It includes advertising, sales promotions, sponsorship of
sports and music events, product placement, viral marketing, and websites and
Internet campaigns (Ewen, 1977; Hawkes, 2006).
Corporations rely heavily on advertising as a tool to encourage consumption of
their products, and evidence shows that for many products advertising is associ-
ated with increased consumption (Chen, Cruz, Schuster, Unger, & Johnson, 2002;
Collins, Schell, Ellickson, & McCaffrey, 2003; Grube & Wallack, 1994; Mastro &
Atkin, 2002; Wakefield, Flay, Nichter, & Giovino, 2003) and positive brand iden-
tification, itself associated with subsequent increases in consumption (Donovan,
Jancey, & Jones, 2002).
Between 1990 and 2005, total inflation-adjusted expenditures on advertising in
the United States increased by 50 percent, a measure of its growing role in busi-
ness spending. In 2005, US advertisers spent $933 per capita. The industries pro-
filed here were among the biggest advertisers; of the nearly $100 billion the top
100 global marketers spent in 2004, 24 percent was devoted to automotive adver-
tising; 17 percent to food, restaurants, soft drinks, and candy; and 9 percent to
pharmaceuticals (Assadourian, 2006).
3.2.1. Increasing Population Exposure to Harmful Products
Most directly, advertising can increase exposure to harmful products, thus magni-
fying their adverse impact on population health. For example, between 1999 and
2004, Merck spent more than $500 million advertising Vioxx to consumers
(Topol, 2004), and in 2003 alone the company spent another $500 million adver-
tising Vioxx to physicians (Brown, 2004). By 2004, when Merck withdrew the
drug because of safety concerns, more than 20 million people had used Vioxx,
generating $10 billion in revenues for the company (Topol, 2004).
Despite the previously described health hazards associated with SUVs, the
automobile industry, the nation’s largest advertiser, has promoted the profitable
SUVs heavily; automakers spent more than $9 billion on SUV ads between 1990
and 2001 (Coate & Vanderhoff, 2001).
3.2.2. Misrepresenting Health Consequences of Products 
in Order to Encourage Consumption
Advertising can also contribute to health problems by understating risks inherent
in products and overstating their potential benefits, leading consumers to choose
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a more dangerous product than they would if they were fully informed. For exam-
ple, despite evidence to the contrary, auto advertisements often suggested that
SUVs were safer than passenger cars (Claybrook, 2003) and that they offered a
way to escape the stresses of every day life by enabling drivers to scale moun-
tains, ford rivers, and enter primal forests.
Merck advertisements implied that Vioxx and other COX-2 inhibitors (drugs in
the same class as Vioxx) were superior painkillers compared to the much less
expensive over-the-counter alternatives (Brown, 2004). Unfortunately, the evi-
dence about the superiority of Vioxx and other COX-2 inhibitors is flimsy
(Modica, Vanhems, & Tebib, 2005). This became particularly important when
evidence emerged about the increased risk of stroke and myocardial infarction
that attended Vioxx use (Topol, 2004).
Further, even when manufactures alert consumers to the adverse consequences
of their products, they often do so in a way intended to minimize the impact.
Although much public health effort has been expended on adding health warnings
to tobacco products and to alcohol and tobacco advertisements, studies have sug-
gested that these notices are developed to minimize their impact (Hammond,
Fong, McNeill, Borland, & Cummings, 2006). One study found that the majority
of adolescents viewing these advertisements do not even notice the public health
warnings (Fischer, Richards, Berman, & Krugman, 1989).
3.2.3. Targeting Vulnerable Populations for Marketing of Harmful Products
All industries seek to target their advertising to potential customers. This practice
affects public health when harmful products are more heavily advertised to popu-
lations who are already at higher risk of health problems. The tobacco industry has
been particularly sophisticated in its use of targeted advertising to increase smok-
ing in particular age, gender, racial/ethnic, and socioeconomic groups. For exam-
ple, tobacco companies have conducted systematic and extensive research to
design cigarette packaging in a way that it is most appealing to target customers
(Wakefield, Morley, Horan, & Cummings, 2002). In addition, several studies have
shown that Black and Latino groups and neighborhoods are disproportionately
exposed to cigarette advertisements (Alaniz & Wilkes, 1998; Balbach, Gasior, &
Barbeau, 2003; King, Siegel, & Pucci 2000; Muggli, Pollay, Lew, & Joseph, 2002;
Wildey et al., 1992), as are poorer persons and neighborhoods (Luke, Esmundo, &
Bloom, 2000). Similarly, tobacco advertising has targeted women, specifically
appealing to their perceived needs and wants (Anderson, Glantz, & Ling, 2005;
Toll & Ling, 2005). Targeted advertising of tobacco to youth occurs in venues
frequented by youth, including bars and clubs (Gilpin, White, & Pierce, 2005;
Sepe & Glantz, 2002) and stores where adolescents shop frequently (Celebucki &
Diskin, 2002; Henriksen, Feighery, Schleicher, Haladjian, & Fortmann, 2004).
Analyses of tobacco industry documents have suggested that industry marketing
has explicitly aimed to target young smokers (Cummings, Morley, Horan, Steger, &
Leavell, 2002), and studies have shown that nearly 90 percent of 13 year olds report
exposure to cigarette marketing (Schooler, Feighery, & Flora, 1996).
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The food industry similarly often targets children. Research has shown that
food advertising during the television programs children watch most is dominated
by advertisements for snack, convenience, and fast foods (Harrison & Marske,
2005), which may have a substantial impact on children’s dietary habits and sub-
sequent adult obesity (Henderson & Kelly, 2005). It has been estimated that
American children see on average 40,000 commercials per year on television, the
majority of which are for unhealthy foods (Horgen, 2005). The food industry has
also targeted schools for marketing campaigns, seeking to capitalize on a captive
population of future lifetime consumers (Shaul, 2000). When faced with growing
evidence about the link between advertising for unhealthy foods and obesity and
the looming threat of regulatory action to control such advertising, large food
companies like Kraft have put a moratorium on food advertising for children
(Mayer, 2005).
The alcohol industry has also targeted advertising at promising customers,
including children and youth, women, minorities, and problem drinkers. These ads
seek to introduce people to drinking and to encourage profitable patterns of
consumption. Tobacco and alcohol billboards have been shown to be more preva-
lent in poor neighborhoods than adjoining better-off neighborhoods (Hackbarth,
Silvestri, & Cosper, 1995; Hackbarth, Schnopp-Wyatt, Katz, Williams, Silvestri,  &
Pfleger, 2001), and alcohol advertising in magazines has specifically targeted gen-
der groups (Alaniz & Wilkes, 1998; Jernigan, Ostroff, Ross, & O’Hara, 2004) and
racial/ethnic groups (Jones-Webb, Baranowski, Fan, Finnegan, & Wagenaar, 1997).
The alcohol industry has also used targeted advertising to shape drinking patterns
among minorities (Cui, 2000), college students (DeJong, 2002), adolescents
(Ellickson, Collins, Hambarsoomians, & McCaffrey, 2005; Garfield, Chung, &
Rathouz, 2003; Grube & Wallack, 1994), and problem drinkers. One study found
that alcohol advertisements in magazines expose young people aged 12 to 20 – and
thus below legal drinking age – to 48 percent more beer advertisements, 20 percent
more distilled spirits advertisements, and 92 percent more “alcopops” advertising
than adults 21 and over (Center on Alcohol Marketing and Youth, 2005). National
studies have demonstrated an association between increased exposure to alcohol
advertising and increased adolescent consumption of alcohol (Snyder, Milici,
Slater, Sun, & Strizhakova, 2006).
Another study found that in the same period that alcohol drinking among
teenage girls increased dramatically, more alcohol advertising reached young
women than young men (Jernigan et al., 2004). A study by the Center on
Addiction and Substance Abuse (Foster, Vaughan, Foster, & Califano, 2006) esti-
mated that 17.5 percent of US alcohol sales in 2001 came from underage drinking
and 20.1 percent from adult “pathological” drinking, a category that used clinical
definitions for alcohol abuse or dependence. These data illustrate the financial
value of targeting these groups for advertising or other promotion.
In the late 1980s and early 1990s, gun manufacturers targeted women for
advertising, using ads that highlighted fear of violence (Hemenway, 2004). Some
studies claim that gun ads target children and youth (Langley, 2001) and that oth-
ers demonstrate misleading claims about the safety benefits of firearms (Vernick,
Teret, & Webster, 1997).
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3.2.4. Bypassing Legal Restrictions on Sale of Unsafe or Unhealthy Products
Advertising also connects buyers to sellers, sometimes bypassing legal controls
or safety standards. For example, one study found that 53 percent of 184 major
city newspapers in the US accepted gun ads for all types of guns, regardless of
whether or not the seller was a licensed gun dealer (Jacobs, 2002: 132). These
advertising practices make it easier for those who cannot purchase guns legally
to acquire a firearm. Similarly, tobacco and alcohol advertising and Internet
sales can help underage consumers to buy these products (Ribisl, Williams, &
Kim, 2003).
In another example, the drug company Parke-Davis promoted off-label use
of gabapentin (brand name Neurontin, an agent to control epilepsy). A review
of industry documents found that the company recruited local doctors to com-
municate favorable messages about gabapentin to their physician colleagues
and paid medical communication companies to develop and publish articles
about gabapentin in the medical literature and to suppress unfavorable study
results (Steinman, Bero, Chren, & Landefeld, 2006). Ultimately, Warner-
Lambert, then owner of Parke-Davis, agreed to plead guilty and pay more then
$430 million to resolve criminal charges and civil liabilities in connection with
its illegal and fraudulent promotion of unapproved uses for the drug (“Drug
maker to pay,” 2004).
3.3. Retail Distribution
Retail distribution refers to industry practices that affect product availability at
the consumer level; manufacturers seek a retail distribution system that makes
their products readily accessible to as many potential consumers as possible.
Placement of fast food outlets, supermarkets or liquor stores; location of products
within stores; adherence with legal industry restrictions on retail practices; or
industry oversight of retail distribution of prescription drugs, firearms, or tobacco
are examples of business decisions that affect product availability and therefore
impact health.
The relationships between producers and retailers are complex and influenced
by both national and local factors. At the national level, the state of the economy,
profit margins in the industry, and the degree to which retailers have independent
political muscle influence their ability to negotiate with producers. Locally, the
competitive environment within various sectors and neighborhoods and the
degree of vertical and horizontal integration with other retailers (e.g., Wal-Mart
vs. the local bodegas) also influence the process and outcome of retailing deci-
sions and thus their impact on health.
3.3.1. Increasing Access to and Availability of Unhealthy Products
Companies use retail distribution systems to make their products widely available
and demonstrate ingenuity and flexibility in devising new retail strategies. For
example, when laws have restricted or banned advertising, the tobacco industry
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has moved to its retail network to find new customers. Tobacco companies have
used incentive programs to ensure placement of tobacco products in visible loca-
tions (Feighery, Ribisl, Clark, & Haladjian, 2003) and made extensive use of
point-of-purchase (POP) promotions (e.g., “buy two, get one free” specials)
(Feighery, Ribisl, Schleicher, Lee, & Halvorson, 2001) to enhance tobacco sales.
Evidence suggests that such promotions increase when limits are imposed on
more traditional advertising. One analysis has shown that POP cigarette promo-
tions increased notably in the aftermath of the tobacco Master Settlement
Agreement (MSA) that imposed price increases and tobacco control programs
(Loomis, Farrely, Nonnemaker, & Mann, 2006). Studies of POP tobacco promo-
tion have found that they increase positive images of smoking and beliefs in the
availability of cigarettes (Donovan et al., 2002; Wakefield, Germain, Durkin, &
Henriksen, 2006).
The food industry also uses POP promotions. Producers and distributors pay
supermarkets to give prominent shelf space to higher-profit food items, often
high-calorie, low-nutrient processed foods or sweetened beverages that contribute
to obesity (Nestle, 2006a). In addition, supermarkets place products in such a way
as to encourage young children to nag their parents to buy heavily advertised,
often sweet and processed food (Nestle, 2006a).
As with tobacco, evidence suggests that retail availability of alcohol influences
patterns of drinking. Point-of-purchase marketing has been shown to increase
alcohol sales and consumption substantially, with one study showing that such
promotions increased beer sales by as much as 17 percent (Beverage Industry,
2001). In a CDC study (2003) of nearly 4,000 alcohol outlets, 94 percent had
some form of POP marketing.
Retail automobile dealers serve as the link between car manufacturers and con-
sumers. The products they choose to promote most heavily, the discounts they
offer, and their role in safety issues influence the vehicles customers purchase.
Because SUVs were more profitable for dealers as well as manufacturers, dealers
played an active role in promoting these vehicles, even though they were less safe
and more polluting than other products (Bradsher, 2002). For example, some
dealers built off-road tracks to allow adventuresome customers to test drive their
SUVs, even though few owners actually go off road.
Retail availability of firearms influences who can get guns for what price. Use
of largely unregulated guns shows, distribution of guns to unlicensed retailers,
and willingness to accept straw purchasers are among the practices that have been
associated with increased access to guns for those who would otherwise be barred
from buying a weapon (Hemenway, 2004). One anecdote illustrates the practice:
In 1999, a Milwaukee gun dealer posted a billboard bragging that his store had
been rated first in sales of guns later used in crimes. The owner reported that the
advertising and ranking helped business (McBride, 1999).
The density of retail outlets also affects product use. For example, a study in
Chicago found that both minors and adults living in neighborhoods with a higher
density of tobacco retail outlets were more likely to smoke than those living in
lower density neighborhoods (Novak, Reardon, Raudenbush, & Buka, 2006).
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Tobacco vending machines and sales of tobacco over the Internet make the prod-
ucts more readily available to minor and adult smokers (Centers for Disease
Control, 1996; Ribisl, 2003).
Similarly, several analyses have shown spatial clustering of fast-food restau-
rants closer to schools, making it easier for children to find products that can
contribute to overweight and obesity. Austin and colleagues (2005) showed that
78 percent of Chicago schools had at least one fast-food restaurant within
800 meters and that there was an estimated 3–4 times as many fast-food restau-
rants within 1.5 kilometers of schools than would be expected if fast-food restau-
rants were randomly distributed throughout the city. A national analysis, using
data from the Behavioral Risk Factor Surveillance Survey, suggested that square
miles per fast-food restaurant and residents per restaurant accounts for 6 percent of
the variance in state obesity rates in multivariable hierarchical models that account
for potential confounders including physical activity and fruit and vegetable intake
(Maddock, 2004). These observations suggest that availability of obesogenic food
may well be deleterious to health in and of itself and may be contributing to the
obesity epidemic that has been extensively documented in the past 15 years.
Higher alcohol outlet density is also associated with higher consumption of
alcohol and higher rates of alcohol-related health problems, including homicide
and gonorrhea (Cohen et al., 2006; Gruenwald & Remer, 2006; Pollack, Cubbin,
Ahn, & Winkleby, 2005).
In the alcohol, firearms and tobacco industries, laws often regulate retail distribu-
tion of these products, limiting access to certain populations. When producers or
retailers oppose these laws or advocate against enforcement, they contribute to wider
availability. One study found that the vigor of enforcement of retail tobacco laws
influences tobacco availability to young people (Jason, Pokorny, Muldowney, &
Velez, 2005). In addition, alcohol retailers seek to use the law to maximize the ven-
ues and hours in which they can sell alcohol in stores, bars, and other settings, further
influencing alcohol availability. In the automobile industry, retail auto dealers play
an active role in lobbying against safety and fuel efficiency regulations, providing the
auto industry with a more acceptable public face (Doyle, 2000).
3.3.2. Decreasing Access to and Availability of Healthy Products
Distributors of lower cost and healthier foods, such as chain supermarkets, may be
less likely to open retail facilities in low-income neighborhoods, in part because of
the perception of lower profit margins, fears of crime, or neighborhood instability.
As a result of such business decisions, disadvantaged communities have less
access to affordable fresh fruits and vegetables and low-fat products. Several
recent studies have documented the lower prevalence of supermarkets in low-
income than in high-income neighborhoods (Moore & Diez-Roux, 2006; Morland,
Wing, Diez-Roux, & Poole, 2002; Zenk et al., 2005).
To what extent are the locations of retail food outlets the result of decisions by
major food companies as compared to more impersonal market forces or choices
by local retailers? Evidence suggests that factors influencing these decisions are
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specific to company, product, time, and place. For example, a vertically-integrated
company such as McDonald’s or Wal-Mart can decide when and where to open
facilities or award franchises, thus giving these corporations a powerful voice in
shaping the retail landscape, the American diet, and inequities in access to healthy
and unhealthy foods (Quinn, 2005; Schlosser, 2001; Spencer et al., 2005). In con-
trast, the observation that the small grocery stores and bodegas prevalent in 
low-income urban neighborhoods (Moore & Diez-Roux, 2006) are less likely to
stock fresh fruits and vegetables or low-fat dairy products (Glanz & Yaroch, 2004)
appears to be a result of various market forces, e.g., turnover and economies of
scale, rather than a central decision by any company.
Pharmacists and retail pharmacy chains make decisions that affect pricing,
drug availability, and the information consumers have about drugs. Studies have
shown that pharmacists often fail to inform consumers about available discounts
(Lewis et al., 2002), thus increasing the price of drugs and presumably decreasing
their availability to some consumers. In addition, some pharmacies have failed to
substitute less expensive generics for more expensive brand name drugs, raising
costs to consumers and profits for retailers and manufacturers. In some cases,
these practices have led to legal action against retail drug stores (National
Legislative Association on Prescription Drug Prices, 2005).
Retailers can also influence gun safety practices. It has been shown that gun
locks are only sporadically available through gun retailers (Milne & Hargarten,
1999), and retailers rarely educate customers about safe gun storage (Sanguino,
Dowd, McEnaney, Knapp, & Tanz, 2002).
3.4. Pricing
Pricing practices determine who pays how much for a product; therefore these
practices influence who is exposed to what level of harmful products. Companies
and their retail affiliates decide how much to charge various customers, whether
or not to engage in legal or illegal price fixing, whether to oppose or support
excise taxes, and how to relate to illicit markets (e.g., untaxed tobacco products).
Producers price products in order to maximize sales. Among the strategies they
use are pricing loss leaders to attract customers who will then become loyal con-
sumers, offering discounts or rebates, fixing prices with other producers to reduce
competition (often an illegal practice), winning public subsidies so as to lower
costs to consumers, and resisting taxes that will increase prices. Pricing practices
influence health when unhealthy products become more attractive because of their
lower price or health-promoting products become less attractive because of higher
prices. We illustrate with a few examples from each of the target industries.
3.4.1. Lowering Prices of Unhealthy Products to Attract New Customers
A variety of evidence shows that as the price of tobacco increases, demand falls.
One estimate suggests that a 10 percent increase in cigarette prices would reduce
overall cigarette consumption by between 2.5 and 5 percent (Chaloupka,
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Wakefield, & Czart, 2001). A review of tobacco company documents showed
that the industry carefully studied the impact of price on demand and developed
pricing strategies, such as promoting lower-cost generic brands, absorbing the
cost of increased excise taxes, and offering discounts and coupons in order to
retain more price-sensitive customers (Chaloupka, Cummings, Morley, &
Horan, 2002). In addition, the tobacco industry has aggressively resisted
increased excise taxes at local, state, and federal levels (Morley, Cummings,
Hyland, Giovino, & Horan, 2002).
The federal government has long subsidized the US food industry, providing
growers and manufacturers with the financial support needed to maintain prices
lower than would be dictated by market forces alone. In recent decades, these
policies have made corn-based products such as corn sweeteners the foundation
of a significant portion of processed food both in the United States and globally;
each year the federal government provides corn growers with $4 billion in direct
payments (Pollan, 2006). Some observers have linked the growing proportion of
calories in the US diet derived from corn sweeteners with the parallel rise of obe-
sity and diabetes (Gross, Li, Ford, & Liu, 2004).
Like other products, alcohol consumption is subject to price elasticity – higher
prices lead to lower consumption. Studies show that beer consumption is insensi-
tive to price while wine and distilled spirits are more sensitive (Chaloupka,
Grossman, & Saffer, 2002). The alcohol industry has been relatively successful in
resisting increased excise taxes, contributing to the decline in the real price of
alcohol in recent decades (Chaloupka, Grossman et al., 2002). In California in
2005, the alcohol industry unsuccessfully campaigned to classify “alcopops” as a
beer rather than a distilled spirit in order to benefit from the lower tax rate for beer
and thus make the product more accessible to the price-sensitive youth market
(Marin Institute, 2006).
As the allure of SUVs declined in recent years, the auto industry has offered a
variety of price incentives, including rebates, discounts, and low-cost loans, in
order to stimulate demand (Warner, 2004). While these efforts have not been able
to reverse the trend, they have served to put more of these unsafe and polluting
vehicles on the road, thus perpetuating their adverse health impact.
In the gun industry, the previously described increase in production of cheap
Saturday night special guns (Wintemute, 1994) in the 1980s and 1990s ensured
that low cost weapons would be available in the low-income communities most
sensitive to price. This pricing strategy contributed to rising gun homicide rates in
these areas in that period. Young people and low-level criminals seeking to pur-
chase guns benefit most from low-cost weapons (Wintemute, 2002).
3.4.2. Raising Prices of Health-Enhancing Products to Increase Profit
Raising prices of health-enhancing products can discourage their use. For exam-
ple, car manufacturers sometimes make new safety technology an option avail-
able at additional cost rather than a standard feature. Although this practice
allows consumers to tailor the purchase to their own economic and safety needs,
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it eliminates the lower price benefits from economies of scale. Thus, the average
customer chooses a lower sticker price – and a less safe vehicle.
The pharmaceutical industry seeks to maintain control of drug prices – usually
advocating for higher prices in order to preserve profits. It opposes more rapid
introduction of generic drugs in order to sustain the monopoly benefits from high-
priced drugs that a company has patented, opposes competition from manufacturers
in other countries that sell at lower prices, opposes legislation that would allow the
government to negotiate bulk discounts on drugs, and supports federal programs
that subsidize drug costs for populations such as senior citizens (Angell, 2004;
Baker, 2004). These practices make good business sense but often make it harder
for individuals to get the drugs they need.
4. Interactions with Other Sectors
In order to achieve their business objectives in investment and product design,
marketing, retail distribution, pricing, and other areas not reviewed here, corpora-
tions and their business associations interact with government, scientists, and
mass media. To the extent that that these interactions influence the health conse-
quences of various corporate practices, they are of interest to public health
researchers. In this section, we describe some of the ways that corporations in the
six target industries seek to influence government, scientists, and mass media to
support their goals.
4.1. Government
Corporations seek to influence all levels and branches of government to advance
business policy objectives that contribute to profitability. In their interactions with
government, corporations and their allies seek to advance their business goals in
the four areas previously described, i.e., investment and product design, market-
ing, retail distribution, and pricing. Their broad goals are to avoid regulation or
other types of public oversight of these and other practices, minimize taxes or
other charges that reduce profits, maximize direct public support for their activi-
ties through subsidies or tax breaks, and retain the right to shift external costs
imposed by their products or practices (e.g., pollution or health harm) to other
sectors. To achieve these objectives, businesses carry out a variety of activities
including lobbying, campaign contribution, litigation, public relations, and
encouragement of a revolving door between government and business. In some
cases, businesses resort to illegal activities such as bribery or influence peddling.
Industry interactions with government are of public health interest when they pre-
vent public officials from acting to protect health and safety or when they result in
the wider availability and distribution of health-damaging products.
Lobbying and other legislative activities are a central tool for advancing
corporate objectives. In 2000, the Center for Responsive Politics estimated
that there were more than 20,000 registered lobbyists in Washington, D.C.
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About 1,000 lobbyists work in the nation’s capital for the food industry (Nestle,
2002) and 675 for the pharmaceutical industry (Brown & Doyle, 2004). More
lobbyists work in state capitals. In the mid-1990s, for example, the tobacco
industry had 25 lobbyists in Minnesota alone (Wolfson, 2001), working to defeat
or water down that state’s tobacco regulations. Between 1998 and 2005, total
reported spending on lobbying increased by 160 percent to $2.28 billion (Center
for Responsive Politics, 2006).
Lobbyists work both to pass beneficial legislation and to defeat harmful laws.
In 2003, for example, the pharmaceutical industry poured millions of dollars into
a concerted – and successful – lobbying effort to convince Congress to pass leg-
islation that would increase coverage of senior citizens for some prescription
drugs and defeat provisions that would have allowed the federal government to
negotiate lower prices on behalf of Medicare patients or import lower-cost med-
icines from Europe or Canada. Analysts estimated the law would increase drug
company profits by $13 billion a year. Pharmaceutical companies acted despite
overwhelming public support for the restrictions they opposed and expert opin-
ion that the measure would leave major gaps in coverage and fail to contain costs
(Connolly, 2003). In 1994, lobbyists for the dietary supplement industry per-
suaded Congress and the President to label dietary supplements as foods rather
than drugs, thus escaping FDA requirements for safety and effectiveness. A few
years later, after aggressive advertising of the benefits of these products, deaths
from supplements, such as ephedra, illustrated the public health costs of this
deregulation and led to calls for renewed public oversight (Fontarosa,
Drummond, & DeAngelis, 2003).
Campaign contributions and other electoral activities help to cement the
friendly relationships between elected officials and industry by increasing the
chances that the legislators or executive branch officials will be grateful or
indebted to lobbyists. Many industry political action committees contribute to
both parties, ensuring influence no matter what the outcome of an election. In
2002, for example, the drug industry contributed about $22 million to the
Republicans and almost $8 million to Democrats (Brown & Doyle, 2004). The
NRA and its gun industry allies offer not only financial support to sympathetic
candidates, but also assistance in voter mobilization and campaigning (Diaz,
1999). This helps to explain why the gun industry and the NRA consistently win
legislative victories even though public opinion polls show high levels of public
support for restrictions on assault rifles and opposition to exempting gun manu-
facturers from liability suits.
Litigation allows industry to delay, weaken, or overturn laws and regulations it
dislikes. Corporations and their allies go to court to seek action against individu-
als, organizations, and government agencies that they perceive as threats to their
business goals. In 2000, for example, seven gun makers filed a suit against the
US Secretary for Housing and Urban Development, the New York State
Attorney General, and other state and local officials, claiming they were violat-
ing the gun makers’ right to sell legal firearms by seeking to force them to accept
a code of conduct on the sale and design of handguns. The manufacturers did not
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seek monetary damages but instead asked the court to bar the officials from try-
ing to convince local police departments to buy weapons only from companies
that had signed the agreement (Brown & Abel, 2003). The automobile industry
has regularly gone to court to challenge state and federal clean air and emission
control legislation (Doyle, 2000).
Public relations fosters a positive public image for corporate America and
blocks proposals that harm its perceived interests (Marchand, 1998). In some
cases, the use of public relations strategies also involve interactions with the
media, described in Section 4.3. When critics challenge the safety of a product,
corporations and their trade associations often respond forcefully, looking to
preclude action to limit profits, to restrict advertising, or to regulate manufactur-
ing or distribution. For example, when the FDA proposed new regulations for
vitamins, industry groups sponsored television ads showing soldiers storming
suburban homes to seize vitamin C bottles (Kessler, 2001). To make their public
messages more credible, industries may create front groups to act as their public
voice. Philip Morris formed the National Smokers Alliance to contest tobacco
regulation (Kessler, 2001), the tobacco, food, and restaurant industries funded the
Center for Consumer Freedom to oppose smoking bans in public places and
lower legal limits on blood alcohol levels (Brownell, 2003: 269), and the auto
industry hired a Washington lobbying firm to create Nevadans for Fair Fuel
Economy Standards, a paper organization that opposed higher mileage standards
that would reduce pollution (Bradsher, 2002: 64).
Public relations seeks to frame the public dialogue on issues relevant to the
industry (Dorfman, Wallack, & Woodruff, 2005), often articulating strikingly
similar messages. These include “market mechanisms, not government action,
provide the best remedies for dangers to consumers,” “it is wrong to restrict
advertising of legal products,” “individuals are responsible for their own behav-
ior,” and “having choices is the American way” (Brownell, 2003; Diaz, 1999;
Menashe & Siegel, 1998). In many cases, public relations expenses are tax
deductible, creating a public subsidy for messages intended to thwart policy
changes to protect health.
The revolving door between government and business ensures that both sides
of the interaction are friendly to corporate interests. For example, presidential
adviser Karl Rove had been chief political strategist for Philip Morris before
working for Bush, and President Bush’s first chief of staff, Andrew Card, had
been General Motors’ top lobbyist in Washington, D.C. (Bradsher, 2002). Daniel
Glickman, secretary of agriculture in the Clinton administration, left office to join
a law firm that lobbies for agriculture and food companies (Nestle, 2002). In
1994, when Philip Morris needed someone to testify against FDA regulation of
tobacco before Congress, it hired former FDA Commissioner Charles Edwards,
paying him $120,000 for the consultancy (Kessler, 2001). In 1998, 128 former
members of Congress were listed as lobbyists, 12 percent of all senators and rep-
resentatives who had left office since 1970 (Abramson, 1998; Nestle, 2002).
Compared to the handful of lobbyists who advocate for public health, these per-
sonal and professional associations between elected and appointed officials and
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corporate lobbyists provide industry with a competitive advantage in influencing
legislation and regulation.
Illegal activities, such as bribery, influence peddling, or price fixing, are
another strategy some corporations have used to advance their objectives. In the
early 1970s, Ford Motor Company fabricated auto safety test data that it submit-
ted to the government, leading to a $7 million fine (Yates, 1983). In 1994, tobacco
industry executives lied under oath to Congress about their prior knowledge of
nicotine’s addictiveness (Kessler, 2001), and in 1999, the US Justice Department
reached a $255 million settlement with the vitamin industry for price fixing, a
practice that made its products more expensive for consumers (Nestle, 2002).
Given spotty enforcement of regulations on corporate behavior, data are not avail-
able to ascertain whether illegal activities constitute the renegade actions of a few
bad apples or a common business practice that endangers public health.
In sum, a variety of evidence shows that corporations act to increase the likeli-
hood that the government will support or at least not oppose their business
agenda. In some cases, these actions prevent or undermine government efforts to
protect public health. To date, systematic investigation of the burden of disease
that can be attributed to these activities has been lacking, suggesting the need for
more research.
4.2. Science
Companies seek to influence the scientific community in order to develop or
redesign more profitable products, win regulatory approval (e.g., FDA approval
of Vioxx), and challenge scientific research that threatens their business interests
(e.g., food industry-sponsored research to challenge university research on role
of trans fats in cardiovascular disease). This strategy contributes to the develop-
ment of unsafe or unhealthy products. Activities to influence science include
sponsorship and publication of research by their own research departments, trade
associations (e.g. the now defunct Tobacco Institute), university-based
researchers, or scientific and professional organizations, as well as contributions
to universities and professional organizations. Examples include food industry
support for nutrition researchers who emphasize exercise rather than diet as the
cause of obesity and several recent cases in which pharmaceutical companies
have been accused of withholding evidence from their own research on the side
effects of their drug products such as Vioxx, Paxil, and others (Harris, 2004;
Topol, 2004).
Krimsky (2003), who has studied corporate behavior related to scientific research,
uses the term “manufactured doubt” to describe the practice of sowing confusion to
avoid or delay regulatory action. In some cases, scientists have hidden the industry
sponsorship of their work, limiting the ability of the scientific community, policy
makers, and the public to assess bias or conflict of interest (Hardell, Walker,
Walhjalt, Friedman, & Richter, 2006). More broadly, some academic leaders have
warned against growing corporate influence on the scientific research enterprise,
compromising universities’ ability to be an independent voice (Bok, 2003).
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4.3. Mass Media
Corporations seek to influence mass media in order to create a social and political
climate favorable to their agenda, to frame their messages, to combat threats to
profitability, and to advance their specific economic, electoral, legislative, legal,
and other policy goals (Ewen, 1996; Marchand, 1998). Activities include public
relations, communications, philanthropy, organization of front groups, and public
service campaigns. For the most part, these activities are seen as standard busi-
ness practices and are therefore tax deductible. Corporations and their allies inter-
act with the media in order to communicate their messages to the general public
and government and more broadly to influence the public discourse on corpora-
tions and their role in society. Activities such as public relations (described above
in Section 4.1), corporate philanthropy, and corporate (as opposed to product)
advertising are of interest to public health to the extent they enable industry to
better distribute products that harm health. Industry can also use its advertising
power to discourage coverage of certain topics. For example, in a stark display of
the power of the tobacco industry, in the 1980s no women’s magazine that
accepted tobacco advertising published a single article, editorial, or column on
the harmful effects of tobacco, despite the fact that it was then that lung cancer
surpassed breast cancer as the leading cause of cancer deaths among women
(Anderson, 1995; Hertz, 2001).
As US and global media ownership becomes more concentrated among a
handful of large multinational corporations (Bagdikian, 2004), often with links
to industries that produce harmful products, the willingness of major media out-
lets to investigate corporate malfeasance or disease promotion may further
diminish.
5. Societal Responses to Health-Damaging 
Corporate Practices
In the 19th century, reformers and public health and social science researchers
called attention to the health impact of the emerging capitalist system. Engels’
The Condition of the Working Class in England described how the English fac-
tory system contributed to the “wretched conditions” of the working class in
England. Nine years later, John Snow, a physician-epidemiologist, convinced a
local London parish to remove the handle from the Broad Street pump that a pri-
vate company used to bring drinking water from a polluted river, contributing to
the epidemic of cholera. Removing the pump handle was an early form of direct
public oversight of corporate practices.
Later, health researchers called attention to the health consequences of working
conditions, documenting higher rates of cancer, injuries, and other conditions
among workers in particular industries. These occupational illnesses were
often exacerbated by corporate unwillingness to sacrifice profits for improved
working conditions. Recent research, for example, has demonstrated that from the
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1920s on, the lead industry hid its knowledge of the toxic results of lead exposure
(Markowitz & Rosner, 2002).
In the 20th century, reformers as well as public health professionals publicized
the risks associated with the practices of various industries. In 1906, Upton
Sinclair published The Jungle, an exposé of dangerous working conditions and
the unsanitary products of the meat industry. In 1964, the US Surgeon General
published the first report on smoking and health, beginning a continuing cam-
paign to reduce the harm from the products of the tobacco industry. A year later,
Ralph Nader published Unsafe at Any Speed, an investigation of the automobile
industry’s failure to protect car owners from known safety hazards. By the 1970s,
consumer advocates were pressing for a federal agency to protect consumers
against industries intent on profiting at the expense of public health.
Today, health professionals; consumer, health and environmental advocates;
local officials; and others are modifying old strategies and developing new ones
to contest corporations’ power to shape health. Like the corporations they chal-
lenge, they have used a variety of strategies and tactics to achieve their goals of
reducing the harm from corporate practices. These include electoral, legislative
and legal strategies, media advocacy, community organizing, and others
(Freudenberg, 2005).
While a review of this emerging domain of public health practice is beyond the
scope of this chapter, several questions warrant further investigation. These
include:
1. To what extent do the disparate activities designed to change corporate prac-
tices in several industries that have been launched by consumer, health and
environmental activists constitute an emerging social movement (Wiist, 2006)?
What are the relative advantages and disadvantages of a more comprehensive
approach to changing corporate behavior as compared to the more common
piece-meal approach?
2. What is the potential for establishing collaborative partnerships with industry
to modify health-damaging practices? Under what political and economic cir-
cumstances will corporations engage in genuine joint ventures, and when are
some efforts more cosmetic than substantive? Some recent evidence suggests
that even when companies agree to cooperate, their practice does not necessar-
ily match their commitment to achieving public health goals (Nestle, 2006b).
3. What are the characteristics of effective public health campaigns to change cor-
porate practices? Are local or regional campaigns more effective than national
ones? What “frames” serve to best mobilize constituencies in support of public
health goals (Dorfman et al., 2005)?
4. What role can state and local health departments play in modifying corporate
practices? Recent efforts to change the practices or density of food, tobacco,
gun and alcohol retailers (Bragg, Galloway, Spohn, & Trotter, 2003; Schneider,
Reid, Peterson, Lowe, & Hughey, 2005; Webster, Vernick, Bulzacchelli, 2006)
or to institute local bans of trans fats in restaurant foods provide examples of
potential roles.
94 Freudenberg and Galea
5. Conclusion
We suggest that in the early part of the 21st century, corporate practices play a
growing role in shaping daily behavior and well-being. In this chapter we have
considered how corporate practices influence the health of populations through
multiple mechanisms. Clearly, the link between corporate practices and any par-
ticular health indicator is complex, and a full understanding of each of the path-
ways linking corporate practices to population health can suggest multiple
opportunities for intervention. Future research in the area can fruitfully both elu-
cidate the precise links between corporate practices and population health and
suggest avenues for intervention.
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